510(k) Clearance: Establishes substantial equivalence to a legally marketed predicate device (21 CFR 807).
PMA Approval: Rigorous evaluation establishing reasonable assurance of safety and effectiveness for high-risk Class III devices.
Adverse Event Disclaimers: Reports from FDA MAUDE represent voluntary notifications and do not verify proven clinical causation.
Premarket Regulatory Records (10)
Audited against FDA CDRH Premarket DatabaseEndoFlow Next-Gen Vascular Stent System
Substantially equivalent or approved for marketing under Section 510(k) or PMA of the FD&C Act.
Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000)
FDA awards Class III Premarket Approval (PMA P960009) for Activa Deep Brain Stimulation Therapy System, Percept PC BrainSense (B32000) sponsored by Medtronic, Inc..
Evolut FX Delivery Catheter System of the Evolut FX Transcatheter Aortic Valve System; Evolut FX+ Transcatheter Aorti
FDA awards Class III Premarket Approval (PMA P130021) for Evolut FX Delivery Catheter System of the Evolut FX Transcatheter Aortic Valve System; Evolut FX+ Transcatheter Aorti sponsored by Medtronic, Inc..
PerClot Absorbable Hemostatic Powder Accessory Tips
FDA awards Class III Premarket Approval (PMA P210036) for PerClot Absorbable Hemostatic Powder Accessory Tips sponsored by Baxter Healthcare Corporation.
Zilver® PTX® Drug-Eluting Peripheral Stent
FDA awards Class III Premarket Approval (PMA P100022) for Zilver® PTX® Drug-Eluting Peripheral Stent sponsored by Cook Ireland, Ltd..
Supera Peripheral Stent System
FDA awards Class III Premarket Approval (PMA P120020) for Supera Peripheral Stent System sponsored by Abbott Vascular (Idef Technologies Inc).
Zilver 635 Vascular Stent, Zilver 518 Vascular Stent
FDA awards Class III Premarket Approval (PMA P050017) for Zilver 635 Vascular Stent, Zilver 518 Vascular Stent sponsored by Cook Ireland, Ltd..
SELUTION SLR 014 PTCA Drug-Eluting Balloon
FDA awards Class III Premarket Approval (PMA P250041) for SELUTION SLR 014 PTCA Drug-Eluting Balloon sponsored by MedAlliance, LLC.
GYNECARE INTERCEED Absorbable Adhesion Barrier
FDA awards Class III Premarket Approval (PMA P880047) for GYNECARE INTERCEED Absorbable Adhesion Barrier sponsored by ETHICON, Inc..
UltraPulse Smart Dual-Chamber Pacemaker
Substantially equivalent or approved for marketing under Section 510(k) or PMA of the FD&C Act.